In a report released on May 22, David Evans from Kepler Capital maintained a Hold rating on Novo Nordisk, with a price target of DKK290.00. The company’s shares closed last Friday at DKK289.00.Meet Samuel – Your Personal Investing ProphetStart a conversation with TipRanks’ trusted, data-backed investment intelligence
Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to TipRanks, Evans is ranked #5608 out of 12214 analysts.
Novo Nordisk has an analyst consensus of Hold, with a price target consensus of DKK273.33, a -5.42% downside from current levels. In a report released on May 20, Deutsche Bank also maintained a Hold rating on the stock with a DKK290.00 price target.
The company has a one-year high of DKK533.40 and a one-year low of DKK224.25. Currently, Novo Nordisk has an average volume of 6.87M.
